Active surveillance for stable ground-glass lung nodules
Part of Lungs & breathing clinical trials.
This study is testing whether careful observation without immediate treatment is safe for people with small, stable lung nodules that look like ground-glass (hazy spots). If you join, the doctors will watch your nodules with regular CT scans to see if they change.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have one or two lung nodules (ground-glass nodules) on a CT scan
- The nodules have been stable (not growing or shrinking) for at least 3 months
- The largest nodule is between 0.6 cm and 2 cm, and mostly not solid
- No enlarged lymph nodes in the chest
- You are between 18 and 75 years old
- You are in good general health (able to do light activity)
- You have not had previous cancer treatment for these lung nodules
- You have not had lung surgery or other lung diseases like fibrosis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for people who have three or more tiny lung spots (called ground-glass nodules or GGNs) that have not changed in at least three months. The goal is to see if carefully monitoring these spots with regular CT scans is a safe and effective approach.
This Phase 2 trial studies whether a procedure called “ablation” is safe and effective for certain lung cancers that appear as ground-glass spots on CT scans and do not improve after 3 months. It may help people who cannot fully have surgery for their condition.
This study looks at whether different lymph node removal methods during lung surgery change outcomes for certain abnormal lung spots. It focuses on ground-glass nodules that stay the same after treatment-free observation and have a mostly solid portion on CT.
This study looks at whether people with a very early type of lung cancer can safely have curative surgery when their CT scan shows a ground-glass type spot with certain size and shape measurements. It aims to help doctors choose the right surgery approach based on the scan features and final pathology.
This study compares a less invasive surgery (wedge resection) for early-stage lung cancer that appears as a ground-glass nodule on CT scans. The goal is to see if this approach works as well as standard surgery while preserving more healthy lung tissue.
This study uses artificial intelligence to analyze CT scans of lung nodules that look like ground glass, which may be early signs of cancer. The goal is to predict how these nodules will grow over time, helping doctors decide whether to monitor or treat them.
Hear when a new Active Surveillance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.